Coverage / CVM / Trade Card

CVM

CEL-SCI Corp

SPECULATIVE BUY 2026-08-01 Updated today USD 1.16 Healthcare - BiotechnologyAWAIT ENTRY
49

Position levels

Currenttoday
USD 1.16
Buy <=wait / entry
USD 0.93
Trim >=take some off
USD 1.40
Thesis breakA material adverse event or interim futility analysis in the Multikine confirmat...
-

Scenario-weighted conviction

ProbabilityScoreContribution
Bull case16%100 / 10016.0
Base case48%62 / 10029.8
Bear case36%10 / 1003.6
Weighted conviction49 / 100 - SPECULATIVE BUY

Top risks

  • Strategic licensing agreement with Saudi partner for Multikine
  • CEO-linked insider buying of 300K shares
  • Q4 2024 EPS beat of -$0.09 vs. est. -$0.11
Read full report →

Research is for informational purposes only. Not financial advice. All analysis reflects the date of publication.